Patient Guide: An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 21 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06075537
Status: ENROLLING_BY_INVITATION
Condition: Mucopolysaccharidosis II
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 21 locations across the country.

Top locations include:
  • • Oakland, California
  • • Chapel Hill, North Carolina
  • • Cincinnati, Ohio
  • • And 18 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007 - Join Clinical Trial NCTNCT06075537

How to Join This Clinical Trial - NCTNCT06075537

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Mucopolysaccharidosis II. Current status: ENROLLING_BY_INVITATION.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Mucopolysaccharidosis II. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Mucopolysaccharidosis II
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
ENROLLING_BY_INVITATION
Study Identifier
NCTNCT06075537 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 21 locations. Find a study site near you:

Clinical Research Site

Oakland, California 94609 - United States

Status: Contact for availability

Clinical Research Site

Chapel Hill, North Carolina 27599 - United States

Status: Contact for availability

Clinical Research Site

Cincinnati, Ohio 45229 - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania 19104 - United States

Status: Contact for availability

Clinical Research Site

Houston, Texas 77030 - United States

Status: Contact for availability

Clinical Research Site

Buenos Aires, - Argentina

Status: Contact for availability

Clinical Research Site

Edegem, Antwerpen 2650 - Belgium

Status: Contact for availability

Clinical Research Site

Jette, - Belgium

Status: Contact for availability

Clinical Research Site

Edmonton, Alberta - Canada

Status: Contact for availability

Clinical Research Site

Toronto, Ontario M5G 1X8 - Canada

Status: Contact for availability

And 11 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Mucopolysaccharidosis II:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships